Mesothelioma Breaking News

1419599_patient12

Alimta May Extend Mesothelioma Survival as a Maintenance Therapy

There is new evidence that mesothelioma patients may live longer with a higher overall dose of the chemotherapy drug pemetrexed (Alimta). Scientists in Japan have just published details of a case they say could be pivotal to the treatment of intractable malignant pleural mesothelioma. Pleural mesothelioma is usually caused by exposure to asbestos and starts […]

physician and colleagues

Catheter Path Tumors in Mesothelioma Patients May Be Benign

Australian cancer researchers have a warning for doctors treating patients with malignant pleural mesothelioma: Not all tumors that arise along pleural needle pathways are malignant. People suspected of having pleural mesothelioma often have some type of intervention that involves inserting a needle into the pleura. This can happen in order to obtain a tissue sample […]

19103717_Immune System

Protein Discovery Could Open Door to New Treatment for 1 in 5 Mesothelioma Patients

A protein expressed on the surface of some mesothelioma cells may play a significant role in how long mesothelioma patients survive. It may also offer a new way to treat the asbestos-linked cancer. That news comes from a team of Spanish researchers presenting their new findings at the European Society of Medical Oncology (ESMO) Conference […]

1 2 3
Navigation
x